bluebird bio Inc (BLUE)
0.8998
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.904
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Cash from Financing (Quarterly): -0.042M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.042M |
| June 30, 2023 | -0.445M |
| March 31, 2023 | 130.46M |
| December 31, 2022 | -0.115M |
| September 30, 2022 | 46.32M |
| June 30, 2022 | 8.034M |
| March 31, 2022 | 0.009M |
| December 31, 2021 | -174.01M |
| September 30, 2021 | 75.87M |
| June 30, 2021 | 0.396M |
| March 31, 2021 | 3.796M |
| December 31, 2020 | 1.432M |
| September 30, 2020 | 1.198M |
| June 30, 2020 | 543.12M |
| March 31, 2020 | 0.963M |
| December 31, 2019 | 2.005M |
| September 30, 2019 | 4.178M |
| June 30, 2019 | 4.781M |
| March 31, 2019 | 10.22M |
| December 31, 2018 | 1.921M |
| September 30, 2018 | 658.79M |
| June 30, 2018 | 5.301M |
| March 31, 2018 | 71.68M |
| December 31, 2017 | 588.33M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.12M |
| June 30, 2017 | 464.85M |
| March 31, 2017 | 16.87M |
| December 31, 2016 | 239.77M |
| September 30, 2016 | 2.433M |
| June 30, 2016 | -1.311M |
| March 31, 2016 | 0.639M |
| December 31, 2015 | 1.017M |
| September 30, 2015 | 3.003M |
| June 30, 2015 | 480.24M |
| March 31, 2015 | 2.464M |
| December 31, 2014 | 246.31M |
| September 30, 2014 | 110.24M |
| June 30, 2014 | 1.225M |
| March 31, 2014 | 0.671M |
| December 31, 2013 | 0.233M |
| September 30, 2013 | -1.181M |
| June 30, 2013 | 106.97M |
| March 31, 2013 | -0.381M |
| December 31, 2012 | -0.015M |
| September 30, 2012 | 59.86M |
| June 30, 2012 | 0.008M |
| March 31, 2012 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-174.01M
Minimum
Dec 2021
543.12M
Maximum
Jun 2020
36.00M
Average
1.718M
Median
Cash from Financing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -119.80M |
| Novavax Inc | 100.39M |
| Motus GI Holdings Inc | 1.09M |
| Tivic Health Systems Inc | 0.00 |
| AIM ImmunoTech Inc | 0.147M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -61.85M |
| Cash from Investing (Quarterly) | 62.08M |
| Free Cash Flow | -286.43M |
| Free Cash Flow Per Share (Quarterly) | -0.5856 |
| Free Cash Flow to Equity (Quarterly) | -63.88M |
| Free Cash Flow to Firm (Quarterly) | -63.88M |
| Free Cash Flow Yield | -313.4% |